Besançon, France

Pierre-Simon Rohrlich

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Etablissement Francais Du Sang. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre-Simon Rohrlich. Retrieved from https://idiyas.com/inventor/pierre-simon-rohrlich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pierre-Simon Rohrlich: Innovator in Biotechnology

Introduction

Pierre-Simon Rohrlich is a notable inventor based in Besançon, France. He has made significant contributions to the field of biotechnology, particularly in the development of diagnostic tools and therapeutic proteins. With a total of 2 patents to his name, Rohrlich's work is recognized for its potential impact on medical science.

Latest Patents

Rohrlich's latest patents include innovative technologies such as the "Truncated CD20 protein, deltaCD20 - Diagnostic kit comprising an oligonucleotide probe for the mRNA encoding a polypeptide having an amino acid sequence substantially identical to that of SEQ ID NO: 2." This diagnostic kit aims to enhance the detection of specific mRNA sequences, which can be crucial for various medical applications. Another significant patent is the "Truncated CD20 protein, deltaCD20 - Isolated nucleic acid sequence encoding the CD20 gene comprising SEQ ID NO: 5, recombinant vector comprising a nucleic acid sequence placed under the control of one or a plurality of elements required for the expression thereof in a host cell, and method for improving the efficacy of a treatment comprising using a nucleic acid sequence comprising SEQ ID NO: 5." This invention focuses on improving treatment efficacy through advanced genetic engineering techniques.

Career Highlights

Pierre-Simon Rohrlich is currently associated with the Établissement Français du Sang, where he applies his expertise in biotechnology to advance research and development in blood-related medical technologies. His work at this institution underscores his commitment to improving healthcare outcomes through innovative solutions.

Collaborations

Throughout his career, Rohrlich has collaborated with esteemed colleagues such as Christophe Ferrand and Marina Deschamps. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

In summary, Pierre-Simon Rohrlich is a distinguished inventor whose contributions to biotechnology are paving the way for advancements in medical diagnostics and treatment. His innovative patents and collaborative efforts reflect his dedication to improving healthcare through scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…